High avidity antigen-specific CTL identified by CD8-independent tetramer staining

Ed Man-Lik Choi1, Ji-Li Chen, Linda Wooldridge

  • 1Tumour Immunology Unit, Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Summary

Tetrameric MHC/peptide complexes can now distinguish high-avidity T cells using mutated CD8 binding sites. This advance aids in comparing vaccine strategies and developing adoptive T cell therapies.